If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

Share Price is delayed by 15 minutes
Get Live Data
48.50    0.00 (0.00%)
Bid:
48.00
Ask:
49.00
Spread: 1.00 (2.083%)
Market Cap: £7.38m
TRT Live PriceLast checked at - London Stock Exchange

Intraday Transense Share Chart

Board and Adviser Change

8 Feb 2008 07:00

Transense Technologies PLC08 February 2008 TRANSENSE TECHNOLOGIES PLC 8 FEBRUARY 2008 BOARD CHANGES; CHANGE OF ADVISER AND OPERATIONAL UPDATE Board Changes Transense Technologies plc ('the Company') announces several Board changes: Jim Perry, until December 2007 the Chief Executive Officer of the Company, andcurrently deputy chairman, will retire from the Board on 31 March 2008, at whichpoint he will be appointed Life President. He will also enter into aconsultancy arrangement for a minimum of 12 months to enable the reconstitutedBoard to have the benefit of his extensive experience and knowledge built upover the last 17 years. Graham Eves, formerly Commercial Director, has resigned with immediate effect.He will remain as a consultant to the Company for 6 months. Howard Pearl will retire as Finance Director following completion of the auditfor the year ended 31 December 2007. He will be replaced in this role by MelvynSegal, who was appointed to the Board in December 2007. Graham Storey has been appointed as a Director with immediate effect. He willassume responsibility for overseeing commercial issues pending the appointmentof a new Managing Director, at which time it is anticipated that he will revertto a non-executive role. The Company is in advanced discussions for the appointment of a Group ManagingDirector. A further announcement will be made in due course. New Adviser The Board is pleased to announce that Brewin Dolphin has been appointed asnominated adviser and broker to the Company with immediate effect. Operational Update: The Board has instigated a strategic review, the main objective of which is todetermine the various means of securing, in the shorter term, a consistent andgrowing revenue stream. The finalisation of this review is unlikely to takeplace before late Spring and pending the arrival of the new Group ManagingDirector. However, it is clear that the stream of royalties in the short termwill be lower than that previously anticipated. On a positive note, there are a number of new projects, upon which the Companyis currently working, which, if they come to fruition, could produce ameaningful flow of income in the medium term. A further announcement will bemade if and when significant progress is made on any of these projects. TheCompany will provide a further trading update at the time of the issue of thepreliminary results scheduled for the end of March. Contacts: Transense Technologies plcDavid Kleeman 0207 430 9329Melvyn Segal 07770 595353 Brewin DolphinNeil Baldwin 0113 241 0126 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Jul 20267:00 amRNS-RNorth American Distribution Partner for Translogik
22nd Jun 20264:11 pmRNSDirector/PDMR Shareholding - acquisition of shares
22nd Jun 20267:00 amRNSTrading update and Investor Meet Company seminar
13th May 20267:00 amRNSGrant of Options
6th May 20267:00 amRNS-RLaunch of high-pressure tyre inspection tool
27th Apr 20263:00 pmRNSDirector/PDMR Shareholding - acquisition of shares
24th Apr 20261:25 pmRNSDirector/PDMR Shareholding - acquisition of shares
22nd Apr 20267:00 amRNS-RSAWsense investment to accelerate scale-up
8th Apr 202612:06 pmRNSHolding(s) in Company
13th Mar 202611:12 amRNSDirector/PDMR Shareholding - acquisition of shares
13th Mar 202611:12 amRNSDirector/PDMR Shareholding - acquisition of shares
13th Mar 20267:00 amRNSAward of major APC-backed project with Cummins
13th Mar 20267:00 amRNSAward of major APC-backed project with Cummins
17th Feb 20267:00 amRNSInterim Results
11th Feb 202610:22 amRNSHolding(s) in Company
9th Feb 20264:49 pmRNSHolding(s) in Company
2nd Feb 202612:36 pmRNSHolding(s) in Company
30th Jan 20267:00 amRNSTrading update and notice of interim results
12th Dec 20257:00 amRNSHolding(s) in Company
26th Nov 20259:04 amRNSResult of AGM
25th Nov 20257:00 amRNSAGM Statement and Trading Update
4th Nov 20257:00 amRNS-RLaunch of Translogik TLGi Smart Tyre Inflator
29th Oct 20259:00 amRNSPosting of Annual Report & Notice of AGM
23rd Sep 20257:00 amRNSFinal Results
12th Sep 20257:00 amRNSNotice of Results
4th Sep 20257:00 amRNS-RProducts update
28th Jul 20253:20 pmRNSTR-1
21st Jul 20253:28 pmRNSDirector/PDMR Shareholding - acquisition of shares
17th Jul 20257:00 amRNSTrading Update
11th Jun 20255:45 pmRNSHolding(s) in Company
21st May 20253:52 pmRNSTR - 1
21st May 20257:00 amRNSDirector/PDMR Shareholding - acquisition of shares
20th May 20257:00 amRNSStrategic US Packaging Collaboration
7th Apr 20253:13 pmRNSHolding(s) in Company
27th Mar 20252:28 pmRNSHolding(s) in Company
21st Mar 202511:38 amRNSHolding(s) in Company
12th Mar 202510:28 amRNSHolding(s) in Company
12th Mar 20257:00 amRNSDirector/PDMR Shareholding - acquisition of shares
4th Mar 202512:26 pmRNSHolding(s) in Company
4th Mar 20257:00 amRNSDirector/PDMR shareholding - acquisition of shares
3rd Mar 20257:00 amRNS-RContract with Logistics UK
25th Feb 202512:02 pmRNSDirector/PDMR shareholding - acquisition of shares
18th Feb 20253:16 pmRNSDirector/PDMR shareholding – acquisition of shares
18th Feb 20257:00 amRNSInterim Results & Investor Presentation
14th Feb 20257:00 amRNSStrategic Partnership with Haltec Corporation
22nd Jan 20257:00 amRNSTrading Update
20th Jan 20251:30 pmRNSAIM Rule 17 Schedule Two (g) update
8th Jan 20251:52 pmRNSDirector/PDMR shareholding – acquisition of shares
17th Dec 20245:02 pmRNSHolding(s) in Company
4th Dec 202411:43 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.